Intuitive Surgical Stock News

Technical traders and technically-minded investors will rejoice after a look at the Intuitive Surgical NASDAQ: ISRG price chart. The market for this leading med-tech company has produced a strong rally since summer, rising $115 from the low to the high in September, or about 30%, and now signaling that the trend will continue for this healthcare company.

A leading robotic surgery stock hit a new high on Friday and is in a buy zone. A telecom stock also hit a new high.

Shares of Intuitive Surgical (ISRG) hit an all-time high Friday, a day after the medical device maker posted better-than-expected results on more use of its da Vinci minimally invasive surgical devices.

Major indexes faded late in Thursday's trading, with the Nasdaq Composite finishing up just .036%.

I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth potential from innovative technology and positive surgeon feedback. Despite strong leadership and market position, ISRG's overvaluation and high WACC of 13% justify the 'Sell' rating.

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q3 2024 Earnings Conference Call October 17, 2024 4:30 PM ET Company Participants Brandon Lamb - Investor Relations Gary Guthart - Chief Executive Officer Dave Rosa - President Jamie Samath - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan David Roman - Goldman Sach...

The robotic surgery leader reported strong Q3 results.

Medical device maker Intuitive Surgical beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its surgical robots used in minimally invasive procedures, sending shares up 6% in extended trading.